hepatitis B

Dynavax's stock plunges after disappointing FDA response to Hep-B treatment
Marketwatch
Mon, 11/14/16 - 11:41 am
Dynavax
hepatitis B
FDA
HEPLISAV-B
Gilead's hepatitis B drug gets U.S. approval
BioPharma Dive
Thu, 11/10/16 - 04:12 pm
Gilead Sciences
Vemlidy
hepatitis B
Arrowhead spanked with clinical hold in hep B
BioPharma Dive
Thu, 11/10/16 - 04:10 pm
Arrowhead
ARC-520
hepatitis B
What Will Dynavax Do if Heplisav-B Is Rejected?
Motley Fool
Sun, 10/16/16 - 12:23 pm
Dynavax
HEPLISAV-B
vaccines
hepatitis B
FDA
FDA Precedent Suggests Dynavax Hep B Vaccine Faces High Rejection Risk
TheStreet.com
Thu, 10/6/16 - 09:22 am
Dynavax
vaccines
hepatitis B
FDA
Heplisav
FDA Adds Boxed Warning to Hepatitis C Drugs, Warns of Hepatitis B Reactivation Risk
RAPS.org
Tue, 10/4/16 - 10:20 pm
FDA
warnings
hepatitis C
hepatitis B
As doubts continue to fester, Inovio gets another shove as Roche exits collaboration
Endpoints
Wed, 08/3/16 - 10:09 am
Roche
Inovio
INO-1800
INO-5150
hepatitis B
Does This Upstart Pose a Threat to GlaxoSmithKline?
Motley Fool
Tue, 05/3/16 - 10:13 am
GSK
Dynavax Technologies
Engerix-B
hepatitis B
vaccines
HEPLISAV-B
Gilead Sciences' Two Phase Three Trials Meet Primary Endpoints
Yahoo/Benzinga
Fri, 04/15/16 - 09:00 am
Gilead Sciences
clinical trials
TAF
hepatitis B
Gilead's 3 Most Profitable Lines of Business
Investopedia
Mon, 03/7/16 - 09:44 am
Gilead Sciences
Truvada
Sovaldi
Harvoni
hepatitis C
hepatitis B
HIV
Gilead Sciences Moves a Step Ahead in HBV Market Gilead Sciences Moves a Step Ahead in HBV Market
Bidness, ETC
Fri, 02/26/16 - 10:28 pm
Gilead Sciences
hepatitis B
Europe
Dynavax, GlaxoSmithKline Battling In Same Industry: Who Will Win?
Yahoo/Benzinga
Wed, 02/24/16 - 10:19 am
Dynavax
GSK
HBV-23
vaccines
hepatitis B
Engerix-B
J&J signs deal with Chinese company for hepatitis B drug
Yahoo/Reuters
Thu, 01/7/16 - 08:53 am
JNJ
China
hepatitis B
Sino Biopharmaceutical
Gilead grabs priority review for pangenotype hep C combo; Hep B med shown to be safe
BioPharma Dive
Wed, 01/6/16 - 11:01 am
Gilead Sciences
hepatitis C
hepatitis B
Sovaldi + velpatasvir
Viread
Johnson & Johnson (JNJ) Efforts To Fight Hepatitis B With Novira
Bidness, ETC
Wed, 11/4/15 - 02:07 pm
JNJ
hepatitis B
Norvira
ContraVir Pharmaceuticals Inc (CTRV) Stock Surged 100% On CMX157 Preliminary Data
Bidness, ETC
Tue, 10/6/15 - 09:53 am
ContraVir
CMX157
hepatitis B
Arrowhead Hits Target In Hepatitis B Drug Trial
Investors.com
Thu, 09/24/15 - 11:52 am
Arrowhead Research
hepatitis B
clinical trials
ARC-520
After Curing Hepatitis C, Gilead Works to Vanquish More Viruses
Bloomberg
Mon, 08/17/15 - 07:15 pm
Gilead Sciences
hepatitis C
hepatitis B
GS-9620
viruses
Abivax May List on Nasdaq After U.S. Lifts Cuba Embargo
Bloomberg
Thu, 07/2/15 - 11:22 am
Abivax
France
NASDAQ
vaccines
Cuba
ABX203
hepatitis B
Abivax tees up a $49M IPO to get its hep B shot into Phase III
Fierce Biotech
Fri, 06/5/15 - 10:38 am
Abivax
IPOs
hepatitis B
vaccines
ABX203
Europe

Pages